Evidence map›Paper›PMID 27706009›Full record

ArticleInternational neurourology journal2016

Social, Economic, and Medical Factors Associated With Solifenacin Therapy Compliance Among Workers Who Suffer From Lower Urinary Tract Symptoms.

Kirill Vladimirovich Kosilov, Loparev Sergay Alexandrovich, Kuzina Irina Gennadyevna, Shakirova Olga Viktorovna, Zhuravskaya Natalia Sergeevna, Ankudinov Ivan Ivanovich

Open access · diamondAbstract read
In one paragraph

Article in International neurourology journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kirill Vladimirovich KosilovDepartment of Social Sciences, School of Humanities, Far Eastern Federal University, Vladivostok, Russian Federation.ORCID 0000-0001-9747-3100
Loparev Sergay AlexandrovichDepartment of Urology, City polyclinic № 3, Vladivostok, Russian Federation.ORCID 0000-0002-5344-716X
Kuzina Irina GennadyevnaDepartment of Social Sciences, School of Humanities, Far Eastern Federal University, Vladivostok, Russian Federation.ORCID 0000-0001-9993-0133
Shakirova Olga ViktorovnaDepartment of Theory and Methods of Adaptive Physical Education, Far Eastern Federal University, Vladivostok, Russian Federation.ORCID 0000-0002-4060-3485
Zhuravskaya Natalia SergeevnaDepartment of Theory and Methods of Adaptive Physical Education, Far Eastern Federal University, Vladivostok, Russian Federation.ORCID 0000-0002-9902-6862
Ankudinov Ivan IvanovichInstitute of Humanities, Far Eastern Federal University, Vladivostok, Russian Federation.ORCID 0000-0002-0399-2194
Far Eastern Federal University · RUSt. Petersburg State Medical Academy "City Polyclinic №44" · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe prevalence of hyperactive-type lower urinary tract symptoms is 45.2%, with shares of overactive bladder (OAB) and urge incontinence (UI) symptoms of 10.7% and 8.2%, respectively. We investigated the possible impact of a wide range of social, economic, and medical factors on compliance with solifenacin treatment in the working population.

methodsSocial, economic, and medical factors as well as the Overactive Bladder questionnaire - the OAB-q Short Form (OAB-q SF), bladder diaries, and uroflowmetry of 1,038 people who were administered solifenacin for a year were gathered from employer documentation.

resultsAmong the subjects, 32% maintained their compliance with solifenacin treatment throughout the year. Only 65% of the patients had compliance exceeding 80%, and 17% of patients had compliance of ≥50%, yet less than 80% were still taking solifenacin 12 months after the beginning of this experiment. Working people whose compliance level was, at least, 80% had reliably higher (P≤0.01) average age, annual salary, and treatment efficacy, and a greater treatment satisfaction level, as well as a lack of satisfaction with other antimuscarinic treatments and higher rate of urge UI diagnosis. The same cohort also featured a lower level (P≤0.01) of caffeine abuse and lower share of salary spent purchasing solifenacin.

conclusionsThis study has shown that compliance with solifenacin treatment is associated with a number of significant medical, social, and economic factors. The medical factors included the type of urination disorder, severity of incontinence symptoms, presence of side effects, treatment efficacy and patients' satisfaction with it, and experience using other antimuscarinic treatments. Among the social and economic factors, those with the strongest correlation to compliance were patient age, employment in medicine and education, annual income level, percentage of solifenacin purchase expenditures, and caffeine abuse. Factors with a weaker, but still significant, association were gender, employment in the transportation industry, and monthly income level.

Indexed as

ComplianceMuscarinic AntagonistsSolifenacin SuccinateUrinary Bladder, Overactive

Identifiers

PMID27706009
PMCPMC5083827
OpenAlexW2524237615

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.